May 6, 2026 07:00AM
Apr 14, 2026 08:04AM
Apr 14, 2026 08:00AM
Mar 30, 2026 09:00AM
Mar 11, 2026 08:00AM
Feb 25, 2026 07:59AM
Feb 25, 2026 07:59AM Tempest Announces Interim Results from Ongoing REDEEM-1 Trial of TPST-2003, Preparing for Potential U.S. Registrational Study in 2026
Jan 20, 2026 05:20PM
Nov 26, 2025 04:05PM
Nov 26, 2025 04:05PM
Nov 25, 2025 08:00AM
Nov 25, 2025 08:00AM
Nov 5, 2025 08:30AM
Sep 8, 2025 07:01AM Biodexa enrolls first patients in Phase 3 trial for FAP treatment
Aug 11, 2025 04:12PM
Jul 28, 2025 07:00AM
Jun 30, 2025 08:10AM
Jun 30, 2025 08:00AM
Jun 11, 2025 08:01AM
Jun 11, 2025 08:00AM
Jun 5, 2025 10:28AM Tempest Therapeutics (TPST) stock rises on EMA Orphan Drug Designation
Jun 5, 2025 08:00AM
May 13, 2025 04:28PM
Apr 28, 2025 04:05PM
Apr 21, 2025 08:01AM
Apr 21, 2025 08:00AM
Apr 10, 2025 06:02AM
Apr 9, 2025 04:30PM Tempest Therapeutics (TPST) Announces Plan to Explore Strategic Alternatives to Advance Promising Pipeline of Clinical Oncology Assets and Maximize Stockholder Value
Apr 9, 2025 04:30PM
Mar 28, 2025 06:47AM
Mar 27, 2025 04:10PM
Mar 25, 2025 04:30PM
Mar 13, 2025 08:00AM
Mar 13, 2025 08:00AM
Feb 10, 2025 08:00AM Tempest Therapeutics (TPST) Granted FDA Fast Track Designation for Amezalpat
Feb 10, 2025 08:00AM
Feb 7, 2025 04:30PM
Jan 6, 2025 08:03AM
Jan 6, 2025 08:00AM
Dec 6, 2024 04:30PM
Nov 25, 2024 04:30PM
Nov 13, 2024 09:30AM Tempest Therapeutics (TPST) PT Lowered to $5 at Piper Sandler
Nov 12, 2024 04:21PM
Nov 12, 2024 08:01AM
Nov 12, 2024 08:00AM
Oct 11, 2024 06:39AM
Oct 10, 2024 07:01AM
Oct 10, 2024 07:01AM
Oct 10, 2024 07:00AM Tempest Extends Limited Duration Stockholder Rights Plan
Sep 20, 2024 04:30PM

323,584 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All